CRESP 25MG INJECTION VIAL
About CRESP 25MG INJECTION VIAL
CRESP 25MG INJECTION VIAL belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). CRESP 25MG INJECTION VIAL helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia.
CRESP 25MG INJECTION VIAL contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. CRESP 25MG INJECTION VIAL is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, CRESP 25MG INJECTION VIAL stimulates the production of this protein in the bone marrow.
CRESP 25MG INJECTION VIAL will be injected by the healthcare provider. Do not self-administer. The most common side effects of CRESP 25MG INJECTION VIAL are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of CRESP 25MG INJECTION VIAL do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to darbepoetin alfa or epoetin alfa, please inform your doctor before taking CRESP 25MG INJECTION VIAL to avoid any complications. Also, mention all the other medications you are taking to affect the way CRESP 25MG INJECTION VIAL works. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be signs that the body has stopped responding to CRESP 25MG INJECTION VIAL.
Uses of CRESP 25MG INJECTION VIAL
Medicinal Benefits
CRESP 25MG INJECTION VIAL is a human-made form of naturally occurring erythropoiesis-stimulating protein or erythropoietin (a hormone produced by the kidney's specialized cells and is responsible for protecting red blood cells against destruction and also stimulates the cells of bone marrow to produce more amount of red blood cells). Deficiency of erythropoietin happens when a person is suffering from chronic kidney diseases, which in turn cause low red blood cells count causing anaemia. This medicine is primarily indicated for treating anaemia (low red blood cell count) in persons with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer except for bone marrow or blood cells' cancer. CRESP 25MG INJECTION VIAL contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells.
Directions for Use
Storage
Side Effects of CRESP 25MG INJECTION VIAL
Drug Warnings
CRESP 25MG INJECTION VIAL can enhance the risk of serious heart problems including heart attack so tell your doctor immediately if you notice shortness of breath, sudden numbness or weakness, chest pain, or trouble speaking or understanding. This medicine may also shorten survival time in some people with certain types of cancer. Inform your doctor before taking CRESP 25MG INJECTION VIAL if you have heart disease, high blood pressure, kidney disease, stroke, heart attack, blood clot, seizure, or latex allergy. Do not take CRESP 25MG INJECTION VIAL if you are pregnant or breastfeeding unless prescribed by the doctor. CRESP 25MG INJECTION VIAL may affect a person's ability to drive as it may cause convulsion during initial days of treatment, so a person taking CRESP 25MG INJECTION VIAL should avoid driving or operating any machine. CRESP 25MG INJECTION VIAL should not be given to children below 12 years of age, as safety and effectiveness have not been established. Avoid consuming alcohol along with CRESP 25MG INJECTION VIAL as it could lead to increased dizziness and sleepiness.
Drug Interactions
Drug-Drug Interactions: CRESP 25MG INJECTION VIAL may have interaction with other chemotherapy drugs (thalidomide), immunosuppressant medication (cyclosporine), antihypertensive medicines (captopril).
Drug-Food Interactions: Avoid alcohol consumption while taking CRESP 25MG INJECTION VIAL as it might cause increased dizziness and sleepiness.
Drug-Disease Interactions: CRESP 25MG INJECTION VIAL may have interactions with disease conditions such as seizures, hemodialysis, hypertension, and thrombotic events
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
Special Advise
Disease/Condition Glossary
Anaemia: It occurs when the body has a lower amount of red blood cells or haemoglobin than normal haemoglobin (iron-rich the protein responsible for allowing red blood cells to carry more oxygen from the lungs to the rest of the body). In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Symptoms of anaemia in chronic kidney disease include fatigue or tiredness, shortness of breath, ashen skin, weakness, body aches, chest pain, dizziness, fainting, fast or irregular heartbeat, headache, sleep problems, and trouble in concentrating.